OÜ PharmaTen
CopyRegistry data
Legal status
Company ID
14915306VAT code
EE102233788Registered
18/02/2020Share capital
2,500.00 €Activity
Retail sale of pharmaceutical products (47731 - EMTAK 2025)Contacts
Company registration address
Website
-
B
HighReliability
B - High
+1 ** during past year
Number of employees
4Credit limit
20-30 k €Credit report
Company's financial performance and creditability assessment.+12.11 % ** during past year
Taxes
16.5KDebts
-
-0.20 % ** during past year
Taxable turnover
331.1K
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Register and
explore Okredo data
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 1,391,126 |
| 695,563 |
| -63,342 |
| -63,342 |
| -31,671 |
| -0.51 |
| -4.99 |
| 5.19 |
| 72,218 |
| 0.10 |
| 1,431 |
| 12.39 |
| -4.55 |
| -196,782 |
| 980,979 |
| 511,636 |
| 272,561 |
| 2023 |
|---|
| 1,291,269 |
| 430,423 |
| -40,131 |
| -40,131 |
| -13,377 |
| -0.25 |
| -2.32 |
| 1.93 |
| 24,949 |
| 0.91 |
| 11,690 |
| 12.24 |
| -3.11 |
| -236,912 |
| 548,803 |
| 82,746 |
| 229,145 |
| 2024 |
|---|
| 1,294,754 |
| 323,689 |
| -4,736 |
| -4,736 |
| -1,184 |
| -0.24 |
| -2.16 |
| 8.05 |
| 104,269 |
| 7.03 |
| 91,030 |
| 15.95 |
| -0.37 |
| -241,649 |
| 522,701 |
| 69,506 |
| 211,546 |
| 2024 |
|---|
| 1,294,754 |
| 323,689 |
| -4,736 |
| -4,736 |
| -1,184 |
| -0.24 |
| -2.16 |
| 8.05 |
| 104,269 |
| 7.03 |
| 91,030 |
| 15.95 |
| -0.37 |
| -241,649 |
| 522,701 |
| 69,506 |
| 211,546 |
Register and
explore Okredo dataTurnover (€)
Register and
explore Okredo dataCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Retail sale of pharmaceutical productsComp. code:
16387550Reg. date:
13/12/2021Turnover:
-No. of employees:
4Category:
Retail sale of pharmaceutical productsComp. code:
16372293Reg. date:
23/11/2021Turnover:
-No. of employees:
5Category:
Retail sale of pharmaceutical productsComp. code:
16086050Reg. date:
29/10/2020Turnover:
-No. of employees:
2Category:
Retail sale of pharmaceutical productsComp. code:
16007151Reg. date:
10/07/2020Turnover:
-No. of employees:
2Category:
Retail sale of pharmaceutical productsComp. code:
14917707Reg. date:
21/02/2020Turnover:
-No. of employees:
4